Cargando…
Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer
BACKGROUND: A patient suffering from metastatic colorectal cancer, treatment-related toxicity and resistance to standard chemotherapy and radiation was assessed as part of a personalized oncogenomics initiative to derive potential alternative therapeutic strategies. PATIENTS AND METHODS: Whole-genom...
Autores principales: | Jones, M. R., Schrader, K. A., Shen, Y., Pleasance, E., Ch'ng, C., Dar, N., Yip, S., Renouf, D. J., Schein, J. E., Mungall, A. J., Zhao, Y., Moore, R., Ma, Y., Sheffield, B. S., Ng, T., Jones, S. J. M., Marra, M. A., Laskin, J., Lim, H. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843189/ https://www.ncbi.nlm.nih.gov/pubmed/27022066 http://dx.doi.org/10.1093/annonc/mdw060 |
Ejemplares similares
-
Immune Activation following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study
por: Titmuss, E., et al.
Publicado: (2023) -
Personalized oncogenomic analysis of metastatic adenoid cystic carcinoma: using whole-genome sequencing to inform clinical decision-making
por: Chahal, Manik, et al.
Publicado: (2018) -
Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers
por: Laskin, Janessa, et al.
Publicado: (2015) -
Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline CHEK2:c.1100delC mutation and a concomitant diagnosis of metastatic invasive ductal breast carcinoma
por: Thibodeau, My Linh, et al.
Publicado: (2017) -
Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy duration
por: Tsang, Erica S., et al.
Publicado: (2023)